Effective Date: September 7, 2016
Expiration Date: September 6, 2019
Format: Self Instructional - Audio Visual Voice-Over with Slides
Maximum Credits: 1.0 AMA PRA Category 1 CME Credit™, 1.0 Nursing Contact Hours (1.0 Pharmacotherapeutic Hours), 1.0 Pharmacy CE (Knowledge Based)
Estimated Completion Time: 1 hour
This program was originally broadcast live September 6, 2016 as part of a webinar sponsored by The Foundation For Care Management and partially supported through an unrestricted educational grant from Novartis.
Heart failure has a profound impact on millions of individuals in the United States and continues to stress the US healthcare system in spite of advances being made in reaching the Healthy People Goal 2010 to decrease the Coronary Heart Disease mortality rates. There are more than one million heart failure-related hospitalizations reported each year, which often result in subsequent rehospitalizations Heart failure is reported as the number one cause of hospitalizations among Medicare patients, which represent more than 80% of all heart failure patients. The burden on hospitals and emergency departments is huge; the cost in terms of financial burden, time loss from work, and local and global impact is staggering.
The goal of this course is to provide the knowledge and tools to equip the Primary Care Provider and Pharmacist to improve the health status of patients with Heart Failure. It includes an audience participated Q&A session and end with a description of a 20 credit hour Performance Improvement Project and an invitation and instructions to enroll in this project without cost.
This program is intended for primary care physicians, physician assistants, nurse practitioners, nurses, and other health care professionals interested in the treatment and management of patients at risk for stroke and working as a team for better patient outcomes.
There is no cost to participate in this program.
Upon completion of this project, the interdisciplinary teams of healthcare providers will be able to:
This course includes a toolkit which may be downloaded from the link provided below as well as from other areas within the course materials:
To View/Download Toolkit: Click Here (PDF file, link will open in new window)
Peter Kudenchuk, MD, FACP, FACC
Professor of Medicine
Division of Cardiology
University of Washington
Professor of Medicine in the Division of Cardiology at the University of Washington. Dr Kudenchuk is board certified in Internal Medicine, Cardiovascular Diseases, and Clinical Cardiac Electrophysiology. He has received numerous awards for excellence in teaching and clinical practice, and recognition as being among the “Best Doctors” in Seattle and in America. He has gained national attention through his publications and lecturing on heart failure and other coronary conditions.
Nicholas David Wyatt, PharmD
Clinical Pharmacy Manager
Harrison Medical Center
University of Washington
Dr. Wyatt is currently a clinical pharmacy manager practicing at Harrison Medical Center. Prior to starting his doctoral studies at the University of Washington School of Pharmacy, Dr. Wyatt spent eight years in the United States Navy-Submarine Force as a Missile Technician managing the worlds’ largest strategic weapons systems.
Dr. Wyatt consistently works to the highest of professional standards and is dedicated to advancing the practice of pharmacy patient care. Dr. Wyatt thrives on challenges and actively participates in multiple facets of pharmacy practice.
It is the policy of Foundation for Care Management (FCM) to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may bementioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by FCM prior to accreditation of the activity. FCM planners and reviewers, outside of those listed, have no relevant financial relationships to disclose.
Dr. Kudenchuk is a small Family Stock holder with Sanofi-Aventis, Johnson & Johnson and Pfizer.
Nicholas Wyatt has nothing to disclose relative to his involvement with this program.
Jeanette M. Dunn, EdD, RN, Lead Nurse Planner, Quality Control Officer, Lisa Chamberlain, Pharm D, have no financial interest in any of the products or manufacturers mentioned. Dr. Kudenchuk, content expert has and is a Small Family Stock holder with Sanofi-Aventis, Johnson & Johnson and Pfizer.
Accreditation Statement: The Foundation for Care Management (FCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for Physicians.
Designation Statement: FCM designates this educational activity for a maximum of 1.0 AMA PRA Category 1 credits™. Physicians should only claim credit commensurate with the extent of the participation in the activity.
The Foundation for Care Management is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Program # 0347-0000-15-019-H01-P. All objectives are appropriate for pharmacists
* This CE activity is knowledge-based.
Accreditation Statement: The Foundation for Care Management is an approved provider of continuing nursing education by the Washington State Nurses Association Continuing Education Approval & Recognition Program (CEARP), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
To receive CME/CE credits, participants must review the program materials in their entirety and complete the online post examination and evaluation with a score of 70% or better. A statement of credit will be available for printing upon successful completion.
If you have questions about this CME/CE activity, please contact FCM at firstname.lastname@example.org.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.